Lockheed Martin has licensed Dermoskeleton bionic augmentation technology from B-Temia.

Under the terms of the agreement, Lockheed will use B-Temia technology in products for military, industrial, commercial and first-responder applications.

B-Temia president and CEO Stéphane Bédard said: "This agreement confirms our company's technology leadership and value of our work in increasing human mobility in both industrial and defense applications.

"Our arrangement with Lockheed Martin provides another avenue for our bionic technology to enhance human performance."

B-Temia's Dermoskeleton is claimed to be the basis for computer-controlled devices that can increase mobility and load-carrying capacity by counteracting overstress on the lower back and legs.

Lockheed Martin Missiles and Fire Control Advanced and Special Programs vice-president Glenn Kuller said: "This technology offers a pathway to increased load bearing and greater agility for our FORTIS industrial exoskeleton.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"This technology offers a pathway to increased load bearing and greater agility for our FORTIS industrial exoskeleton."

"It can also help to solve existing limitations of powered exoskeletons for our military and first responders. We're excited about the potential we see here."

The Dermoskeleton uses high-end sensors and advanced artificial intelligence proprietary software to sense the user’s mobility intentions and generate synchronised movements at the motorised knees.

This robotic system is capable of sensing the intended movement and it can provide the right level of assistance in perfect symbiosis with the body motion, B-Temia stated.

Lockheed's FORTIS exoskeleton is an unpowered, lightweight exoskeleton designed to increase an operator's strength and endurance by transferring the weight of heavy loads from the operator's body directly to the ground through a series of joints at the hips, knees and ankles.

Image: Lockheed Martin’s agreement with B-Temia allows it to use the latter’s proprietary Dermoskeleton technology. Photo: courtesy of Lockheed Martin.